Skip to main content
Have a personal or library account? Click to login
Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme Cover

Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme

Radiology and Oncology
Volume 47 (2013): Issue 4 (December 2013)
By: ,  ,  ,  ,  ,   and    
Open Access
|Oct 2013
References

References

  1. 1. Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, et al. Epidemiology of glial and non-glial brain tumors in Europe.2012;1532-42.
    Open DOISearch in Google Scholar
  2. 2. Lee CH, Jung KW, Yoo H, Park S, Lee SH. Epidemiology of primary brain and central nervous system tumors in Korea.2010;145-52.
    Open DOISearch in Google Scholar
  3. 3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.2005;987-96.
    Open DOISearch in Google Scholar
  4. 4. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.1978;333-43.
    Open DOISearch in Google Scholar
  5. 5. Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A, et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.2010;377-81.
    Open DOISearch in Google Scholar
  6. 6. Kase M, Vardja M, Lipping A, Asser T, Jaal J. Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme.2011;127-31.
    Open DOISearch in Google Scholar
  7. 7. Mannino M, Chalmers AJ. Radioresistance of glioma stem cells: intrinsic characteristic or property of the ‘microenvironment-stem cell unit’?2011;374-86.
    Search in Google Scholar
  8. 8. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.2006;756-60.
    Open DOISearch in Google Scholar
  9. 9. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumor initiating cells.2004;396-401.
    Open DOISearch in Google Scholar
  10. 10. Laks DR, Visnyei K, Kornblum HI. Brain tumor stem cells as therapeutic targets in models of glioma.2010;633-40.
    Open DOISearch in Google Scholar
  11. 11. Dell’Albani P. Stem cell markers in gliomas.2008;2407-15.
    Open DOISearch in Google Scholar
  12. 12. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.2008;8205-12.
    Open DOISearch in Google Scholar
  13. 13. Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, et al. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.2011;162-74.
    Open DOISearch in Google Scholar
  14. 14. Hermansen SK, Christensen KG, Jensen SS, Kristensen BW. Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma.2011;391-407.
    Open DOISearch in Google Scholar
  15. 15. Pistollato F, Abbadi S, Rampazzo E, Persano L, Della Puppa A, Frasson C, et al. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.2010;851-62.
    Open DOISearch in Google Scholar
  16. 16. Sheehan JP, Shaffrey ME, Gupta B, Larner J, Rich JN, Park DM. Improving the radiosensitivity of radioresistant and hypoxic glioblastoma.2010;1591-1601.
    Open DOISearch in Google Scholar
  17. 17. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.2003;79-88.
    Search in Google Scholar
  18. 18. Metellus P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, et al. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.2011;2937-45.
    Open DOISearch in Google Scholar
  19. 19. Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, et al. CD133/prominin 1 is prognostic for GBM patients survival, but inversely correlated with cysteine cathepsins expression in glioblastoma derived spheroids.2011;102-15.
    Open DOISearch in Google Scholar
  20. 20. Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z, et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.2008;85
    Open DOISearch in Google Scholar
  21. 21. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.2008;808-15.
    Open DOISearch in Google Scholar
  22. 22. Jamal M, Rath BH, Tsang PS, Camphausen K, Tofilon PJ. The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.2012;150-58.
    Open DOISearch in Google Scholar
  23. 23. McCord AM, Jamal M, Williams ES, Camphausen K, Tofilon PJ. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.2009;5145-53.
    Open DOISearch in Google Scholar
  24. 24. Jamal M, Rath BH, Williams ES, Camphausen K, Tofilon PJ. Microenvironmental regulation of glioblastoma radioresponse.2010;6049-59.
    Open DOISearch in Google Scholar
  25. 25. Christensen K, Schroder HD, Kristensen BW. CD133+ niches and single cells in glioblastoma have different phenotypes.2011;129-43.
    Open DOISearch in Google Scholar
  26. 26. Schwartzbaum JA, Huang K, Lawler S, Ding B, Yu J, Chiocca EA. Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma.2010;320-27.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0055 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 405 - 410
Published on: Oct 8, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
glioblastoma multiforme,
CD133,
stem cells,
radiotherapy,
survival
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2013 Marju Kase, Ave Minajeva, Kristi Niinepuu, Sandra Kase, Markus Vardja, Toomas Asser, Jana Jaal, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 47 (2013): Issue 4 (December 2013)
Previous article
Next article